GP6 Antibody

Code CSB-PA872550LA01HU
Size US$166
Order now
Image
  • IHC image of CSB-PA872550LA01HU diluted at 1:600 and staining in paraffin-embedded human bladder cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.

  • IHC image of CSB-PA872550LA01HU diluted at 1:600 and staining in paraffin-embedded human glioma performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.

  • Immunofluorescence staining of MCF-7 cells with CSB-PA872550LA01HU at 1:200, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) GP6 Polyclonal antibody
Uniprot No.
Target Names
GP6
Alternative Names
Glycoprotein 6 antibody; Glycoprotein VI antibody; GP6 antibody; GPIV antibody; GPVI antibody; GPVI_HUMAN antibody; MGC138168 antibody; Platelet collagen receptor antibody; Platelet glycoprotein VI antibody; Platelet glycoprotein VI precursor antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human Platelet glycoprotein VI protein (115-265AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The GP6 Antibody (Product code: CSB-PA872550LA01HU) is Non-conjugated. For GP6 Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA872550LB01HU GP6 Antibody, HRP conjugated ELISA
FITC CSB-PA872550LC01HU GP6 Antibody, FITC conjugated
Biotin CSB-PA872550LD01HU GP6 Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Tested Applications
ELISA, IHC, IF
Recommended Dilution
Application Recommended Dilution
IHC 1:500-1:1000
IF 1:200-1:500
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Collagen receptor involved in collagen-induced platelet adhesion and activation. Plays a key role in platelet procoagulant activity and subsequent thrombin and fibrin formation. This procoagulant function may contribute to arterial and venous thrombus formation. The signaling pathway involves the FcR gamma-chain, the Src kinases (likely FYN or LYN) and SYK, the adapter protein LAT and leads to the activation of PLCG2.
Gene References into Functions
  1. there is an altered activation state of GPVI signaling in ST-elevation myocardial infarction patients; GPVI is critical for the formation of arterial thrombosis in vivo PMID: 28004756
  2. haplotype PEAN associated with SPS and manifested by fetal loss and suggest that the mechanism involved in the action of GPVI has significant effect on GPVI-mediated signal transduction through Syk-phosphorylation. PMID: 28041267
  3. This suggests whereas platelet receptor shedding is mainly modulated by calcium-dependent signals, either platelet-surface interactions with the container walls during storage or induced shear stress under long-term agitation, might be also involved in the excessive shedding of GPVI during the storage of PRP-platelet concentrates. PMID: 27778530
  4. There was no evidence to suggest that polymorphisms of GP VI T13254C and GP Ibalpha VNTR were associated with CAD. PMID: 28607925
  5. Platelet adhesion to collagen induces GPVI dimer clustering. GPVI clustering increases both avidity for collagen and the proximity of GPVI-associated signaling molecules, which may be crucial for the initiation and persistence of signaling PMID: 28058806
  6. Loss of the platelet surface receptors GPIbalpha and GPVI in heart failure, CF-VAD and ECMO patients may contribute to ablated platelet adhesion/activation, and limit thrombus formation under high/pathologic shear conditions PMID: 27601054
  7. SGPVI was significantly lower in patients treated with NOACs. PMID: 27693274
  8. Novel antithrombotic peptides derived from trowaglerix that acts through GPVI antagonism with greater safety-no severe bleeding. PMID: 28596377
  9. rs1613662 polymorphism has an important role in the development of venous thromboembolism in the white race PMID: 28353616
  10. plasma sGPVI levels are related to platelet activation in Living Donor Liver Transplantation. Although the plasma levels of sGPVI in the survivors increased after the operation, those in the nonsurvivors were high only on day 3. PMID: 26346441
  11. results support the idea that genetic variability of GP6 regulatory regions can be associated with platelet hyperaggregability - a possible cause of miscarriage PMID: 26308704
  12. These results demonstrate that GP6 is a receptor for fibrin and provide evidence that this interaction contributes to thrombus growth and stability. PMID: 26282541
  13. data suggest a novel role for FAK in GPVI-dependent ROS formation and platelet activation and elucidate a proximal signaling role for FAK within the GPVI pathway. PMID: 25415317
  14. As sCD147 strongly correlates with platelet-specific sGPVI, a common platelet source and/or mechanism of release may contribute to sCD147 levels in vivo. PMID: 24245520
  15. This study identifies GPVI as a platelet receptor for polymerized fibrin with 2 major functions: (1) amplification of thrombin generation and (2) recruitment of circulating platelets to clots. PMID: 25977585
  16. measuring the level of sGPVI may be useful for assessing the activation of platelets in postoperative patients treated with anti-Xa agents and also for predicting the incidence of VTE in this population. PMID: 25253166
  17. Glaucocalyxin A inhibits platelet activation and thrombus formation preferentially via GPVI signaling pathway. PMID: 24386454
  18. The plasma levels of sGPVI were the highest in patients with TMA without markedly reduced ADAMTS13 and those were significantly reduced after plasma exchange. PMID: 24325877
  19. Results suggest that variants of GP6 SNPs, namely, rs1671153, rs1654410, rs1654419, and rs1613662, may be associated with risk of recurrent miscarriage. PMID: 25086789
  20. Lower platelet GPIV levels are associated with no-reflow phenomenon in patients with acute myocardial infarction. PMID: 24126767
  21. Studies indicate that Megakaryocyte maturation is accompanied by up-regulation of glycoprotein VI and down-regulation of leukocyte-associated immunoglobulin-like receptor-1. PMID: 20713462
  22. PAR4 and GPVI-mediated platelet reactivity involves 12-lipoxygenase PMID: 23784669
  23. RhoG is expressed and activated in platelets, plays an important role in GPVI-Fc receptor gamma-chain complex-mediated platelet activation, and is critical for thrombus formation in vivo. PMID: 24106269
  24. SNPs tested within the GPVI gene are not associated with rheumatoid arthritis susceptibility and/or severity. PMID: 23739280
  25. Results suggest that p21 activated kinase serves as an orchestrator of platelet functional responses after activation downstream of the platelet collagen receptor, glycoprotein receptor VI. PMID: 23640496
  26. In response to GPVI stimulation, OPHN1 becomes phosphorylated at Tyr370 and plays a role in the formation of filopodia during platelet spreading on collagen. PMID: 23619296
  27. analysis of hierachical protein recruitment to the inhibitory platelet receptor, G6B-b PMID: 23185356
  28. Our results, especially higher occurrence of four haplotypes in SPS patients, can support an idea that variability of the GP6 gene may be associated with the platelet hyperaggregability insticky platelet syndrome. PMID: 23168074
  29. Interaction between integrin alpha2beta1 and collagen type I takes place prior to collagen receptor activation. PMID: 23132859
  30. GP6 SNPs 1613662-G, 1671153-G and 1654419-A alleles are associated with an increased risk for deep venous thrombosis and sticky platelet syndrome. PMID: 22821001
  31. Reactive oxygen species generation downstream of GPVI or FcgammaRIIa consists of two distinct phases: an initial Syk-independent burst followed by additional Syk-dependent generation. PMID: 22489915
  32. Results support the idea that GP6 gene polymorphism may be associated with platelet hyperaggregability, a possible cause of fetal loss. PMID: 22901851
  33. The GPVI-specific agonist collagen-related peptide or thrombin further increases the number of dimers, thereby providing a feedback mechanism for reinforcing binding to collagen and platelet activation. PMID: 22773837
  34. analysis of platelet GPVI, a unique platelet-specific receptor with uses in diagnosis and/or disease prevention [review] PMID: 22274761
  35. Exposure of platelets to high shear induced a metalloproteinase-dependent GPVI cleavage, producing a ~55-kDa soluble ectodomain fragment & A ~10-kDa platelet-associated tail fragment. This may down-regulate GPVI expression. PMID: 22431567
  36. Collagen receptor GPVI is platelet-specific, constitutively expressed, and key regulator of thrombosis. Enhanced surface expression is associated with atherosclerotic diseases such as acute coronary syndrome and ischemic stroke. [review-type article] PMID: 21718237
  37. A preclinical tool (human GPVI as an antiplatelet target) is developed in a genetically modified mouse strain to evaluate the role of GPVI in various models of thrombosis. PMID: 22238212
  38. The rapid assembly of highly competent dimers of GPVI at sites of vascular lesion represents an important step in the sequence of events leading to platelet activation by collagen. PMID: 22155453
  39. Platelet GPVI surface expression is enhanced in patients with acute coronary syndrome with unclear electrocardiogram (ECG) findings and is strongly associated with myocardial ischemia. PMID: 20071043
  40. The effect of GPVI stimulation on levels of specific proteins in subcellular platelet compartments was compared and analysed. PMID: 22114104
  41. Polymorphic variation at the GP6 locus is associated with risk of acute myocardial infarction in men and women. PMID: 20227257
  42. the functional interactions between SSL5 and platelets, including the novel finding of a role for the GPVI receptor PMID: 21552524
  43. Coagulation-induced GPVI shedding via FXa down-regulates GPVI under procoagulant conditions. PMID: 21252089
  44. the minor allele of GP6 T13254C that reduces platelet activation and aggregation also may be associated with a reduced incidence of recurrent cardiovascular events and mortality, but is not associated with first MI PMID: 20723028
  45. Glycoprotein VI shedding is implicated in the pathology of acute ischemic stroke. PMID: 21193745
  46. In platelets, SLAP-2 may have function as a negative regulator of GPVI-mediated signaling by interacting with c-Cbl. PMID: 20828795
  47. A unique megakaryocytic cell line UT-7/TPO could respond to one of the primary platelet signals through GP (glycoprotein) VI and a secondary signal of the AA (arachidonic acid) cascade. PMID: 20522022
  48. Ablation of TULA-2 resulted in hyperphosphorylation of Syk and its downstream effector phospholipase C-gamma2 as well as enhanced platelet glycoprotein VI-mediated platelet functional responses. PMID: 20585042
  49. [review]role of GP6 in platelet activation and blood clotting; blockade of collagen binding to GPVI PMID: 20414836
  50. Data indicate signaling events triggered by specific ligation of GPIbalpha can lead to robust platelet activation, similar to GPVI, and help define GPIb-IX-V as both an adhesion and signaling receptor on platelets. PMID: 20367574

Show More

Hide All

Involvement in disease
Bleeding disorder, platelet-type 11 (BDPLT11)
Subcellular Location
[Isoform 1]: Cell membrane; Single-pass membrane protein.; [Isoform 2]: Cell membrane; Single-pass membrane protein.
Tissue Specificity
Megakaryocytes and platelets.
Database Links

HGNC: 14388

OMIM: 605546

KEGG: hsa:51206

STRING: 9606.ENSP00000308782

UniGene: Hs.661752

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
webinars: DT3C facilitates antibody internalization X
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*